本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Relay Therapeutics

20.45
+0.68503.47%
成交量:62.48萬
成交額:1,270.91萬
市值:44.80億
市盈率:-13.06
高:20.55
開:20.10
低:20.05
收:19.76
52周最高:21.27
52周最低:3.44
股本:2.19億
流通股本:1.45億
量比:0.62
換手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-1.5651
每股收益(LYR):-1.6113
淨資產收益率:-36.77%
總資產收益率:-22.88%
市淨率:5.03
市盈率(LYR):-12.69

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]